Table 2.
Patient Presentation | No./Total (N = 502) (%) |
---|---|
Epidemiologic risk factors for COVID-19 | |
Admitted from congregate settinga | 155/502 (31) |
Known exposure to COVID-positive individual | 199/502 (40) |
Healthcare worker | 35/502 (7) |
Physician | 6/35 (17) |
Nurse | 11/35 (31) |
Other | 18/35 (51) |
Evaluation location | |
Patients evaluated prior to admission | 218/502 (43) |
ED evaluationb | 133/502 (61) |
COVID assessment site | 35/502 (16) |
Other | 50/502 (23) |
Testing timing | |
Patients with positive SARS-CoV-2 assay during admission | 366/502 (73) |
Mean time to positive test after admission, days | 1.6±2.9 |
Patients with positive SARS-CoV-2 assay prior to admission | 79/502 (16) |
Mean time to positive test prior to admission, d | 0.7±2.3 |
Not reported | 57/502 (11) |
Hospitalized location, state | |
Arkansas | 56/502 (11) |
North Carolina | 76/502 (15) |
Louisiana | 80/502 (16) |
Mississippi | 127/502 (25) |
Tennessee | 163/502 (32) |
Clinical presentation | |
Fever (Tmax >38°C in house or prior to admission) | 352/502 (70) |
Productive cough | 80/502 (16) |
Dry cough | 277/502 (55) |
Dyspnea | 317/502 (63) |
Night sweats | 27/502 (5) |
Chills | 94/502 (19) |
Sore throat | 36/502 (7) |
Fatigue | 187/502 (37) |
Anorexia | 80/502 (16) |
Myalgia | 142/502 (28) |
Nasal congestion | 45/502 (9) |
Rhinorrhea | 37/502 (7) |
Nausea | 105/502 (21) |
Vomiting | 66/502 (13) |
Diarrhea (>3 episodes of loose stool within previous 24 h) | 104/502 (21) |
Abdominal pain | 49/502 (10) |
Headache | 70/502 (14) |
Rash | 2/502 (0) |
Anosmia (loss of smell) | 25/502 (5) |
Ageusia (loss of taste) or dysgeusia (altered taste) | 36/502 (7) |
Psychataxia (difficulty concentrating) | 29/502 (6) |
Pleurisy/chest pain | 57/502 (11) |
No. of patients reporting symptoms prior to admission | 471/502 (94) |
Mean duration of symptoms prior to admission, d | 5.2±4.5 |
Note. ED, emergency department.
Congregate setting is a school, workplace, prison, etc.